M. Sinn
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in ⓘ
- Co-authors
- Hanno Riess (7 shared papers)Uwe Pelzer (8 shared papers)Marcus Bahra (7 shared papers)Jana K. Striefler (6 shared papers)Philipp Lohneis (5 shared papers)Helmut Oettle (6 shared papers)Bernd Dörken (4 shared papers)Jens Stieler (4 shared papers)
- Journals
- Annals of Oncology (8 papers)European Journal of Cancer (2 papers)British Journal of Cancer (1 paper)Journal of Hepatology (1 paper)Frontiers in Physiology (1 paper)
- Partner nations
- GermanyUnited KingdomAustralia
In The Last Decade
M. Sinn
17 papers receiving 509 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Internal Medicine 142
- Oncology 291
- Emergency Medical Services 49
- Cancer Research 83
- Cardiology and Cardiovascular Medicine 103
Countries citing papers authored by M. Sinn
This map shows the geographic impact of M. Sinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sinn more than expected).
Fields of papers citing papers by M. Sinn
This network shows the impact of papers produced by M. Sinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sinn. The network helps show where M. Sinn may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Sinn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline Hit paper breakdown → | 2023 | 172 |
| 2 | 2014 | 112 | |
| 3 | 2014 | 63 | |
| 4 | 2017 | 39 | |
| 5 | 2015 | 34 | |
| 6 | 2013 | 32 | |
| 7 | 2020 | 22 | |
| 8 | 2014 | 16 | |
| 9 | 2021 | 9 | |
| 10 | [Propranolol for prophylaxis of migraine (author's transl)]. | 1977 | 6 |
| 11 | 2017 | 3 | |
| 12 | 1989 | 3 | |
| 13 | 2020 | 2 | |
| 14 | 2024 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2021 | 0 | |
| 19 | 2019 | 0 |
About M. Sinn
M. Sinn is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 517 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Genetic factors in colorectal cancer (2 papers), Pancreatitis Pathology and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Internal Medicine (142 citations), Oncology (291 citations), Emergency Medical Services (49 citations), Cancer Research (83 citations) and Cardiology and Cardiovascular Medicine (103 citations). M. Sinn has collaborated with scholars based in Germany, United Kingdom and Australia. Frequent co-authors include Hanno Riess, Uwe Pelzer, Marcus Bahra, Jana K. Striefler, Philipp Lohneis, Helmut Oettle, Bernd Dörken, Jens Stieler, Carsten Denkert and Anthony Maraveyas. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, Journal of Hepatology and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.